Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
BioCell Innovations Pte Ltd is a Biotechnology Research brand in Singapore. Ownership is privately held; it publishes at biocell.com.sg. It holds one address on record, all in Singapore. The record counts 11 people. Tagged lentiviral Vectors, CAR T Cell Therapy and allogeneic platform. One Singapore registration (UEN) is a confirmed match. It is listed alongside eight similar brands, mostly in Biotechnology Research.
UEN202326501W
| BIOCELL INNOVATIONS PTE. LTD. | UEN 202326501W |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
BioCELL Innovations is a Singapore-based company with the primary objective to bring cell and gene therapy to patients-in-need, offering them effective and personalized treatment options. BioCELL specializes in Chimeric Antigen Receptor (CAR) T cell therapy, and is developing in-house CAR constructs for both autologous and allogeneic platforms.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Singapore entity on ACRA. BIOCELL INNOVATIONS PTE. LTD. (UEN 202326501W), high confidence.
The record holds 11 counted staff profiles at January 2026, above the self-reported 2–10 band.
One address on record, Singapore only. Primary: 100 Pasir Panjang Road, #03-03, Singapore 118518.
None linked to this brand.
Four tags on the brand's own list, among them Lentiviral Vectors, CAR T Cell Therapy and Allogeneic platform.
Eight peer profiles on record: Mirxes and Tessa Therapeutics Ltd.